These recognitions reflect UNAMs steady progress in research output, academic reputation, innovation, and international engagement
Cardiometabolic Benefits and Risk-Related Markers Cagrilintide research also extends to cardiometabolic biology, especially where researchers are interested in the relationship between weight-related signaling, glycemic control, and broader metabolic risk markers
R., Ahmann, A., Cariou, B., Chow, F., Davies, M
Sun Z, Zhang S, Chan JY, Zhang DD
The American Diabetes Association (ADA) recognizes the cardiovascular benefits of GLP-1 receptor agonists in their Standards of Care but does not currently recommend these agents solely for inflammation management outside established indications for diabetes, obesity, or cardiovascular risk reduction